EU Panel Votes to Expand Dulaglutide Indication Based on REWIND EU Panel Votes to Expand Dulaglutide Indication Based on REWIND

The panel also recommends approval of Qtrilmet, a fixed-dose combination of metformin hydrochloride/saxagliptin/dapagliflozin for treatment of type 2 diabetes.International Approvals
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Diabetes & Endocrinology News Alert Source Type: news